Comparative Risk of Harm Associated with Zopiclone or Trazodone Use in Nursing Home Residents: a Retrospective Cohort Study in Alberta, Canada.

Background There is growing evidence of harm associated with trazodone and nonbenzodiazepine sedative hypnotics (e.g., zopiclone); however, their comparative risk of harm is unknown. Methods We conducted a retrospective cohort study with linked health administrative data, which enrolled older ( ≥66...

Descripción completa

Detalles Bibliográficos
Publicado en:Canadian Geriatrics Journal Vol. 26; no. 1; pp. 9 - 23
Autores principales: Watt, Jennifer A., Bronskill, Susan E., Meng Lin, Youngson, Erik, Ho, Joanne, Hemmelgarn, Brenda, Straus, Sharon E., Gruneir, Andrea
Formato: research tables/charts Journal Article
Publicado: Canadian Geriatrics Society Mar2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=162251458&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 162251458
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19258348
        EV2Z
      jtl: Canadian Geriatrics Journal
      issn: 19258348
      maglogo: N
    pubinfo:
      dt: Mar2023
      vid: 26
      iid: 1
      pid: 76420
      pub: Canadian Geriatrics Society
      place: Markham, Ontario
    artinfo:
      ui:
        162251458
        162251458
        162251458
        10.5770/cgj.26.622
        162251458
      ppf: 9
      ppct: 14
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Comparative Risk of Harm Associated with Zopiclone or Trazodone Use in Nursing Home Residents: a Retrospective Cohort Study in Alberta, Canada.
      aug:
        au:
          Watt, Jennifer A.
          Bronskill, Susan E.
          Meng Lin
          Youngson, Erik
          Ho, Joanne
          Hemmelgarn, Brenda
          Straus, Sharon E.
          Gruneir, Andrea
        affil: Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital-Unity Health Toronto, Toronto, ON
      sug:
        subj:
          Trazodone Therapeutic Use
          Trazodone Adverse Effects
          Eszopiclone Therapeutic Use
          Eszopiclone Adverse Effects
          Nursing Home Personnel Psychosocial Factors
          Osteoporotic Fractures Risk Factors
          Risk Assessment
          Manuscripts
          Canada
          Adverse Drug Event
          Prospective Studies
          Descriptive Statistics
          Retrospective Design
          Administrative Research
          Male
          Female
          Resistance Training
          Confidence Intervals
          Databases, Health
          Male
          Female
      ab: Background There is growing evidence of harm associated with trazodone and nonbenzodiazepine sedative hypnotics (e.g., zopiclone); however, their comparative risk of harm is unknown. Methods We conducted a retrospective cohort study with linked health administrative data, which enrolled older ( ≥66 years old) nursing home residents living in Alberta, Canada, between December 1, 2009, and December 31, 2018; the last followup date was June 30, 2019. We compared the rate of injurious falls and major osteoporotic fractures (primary outcome) and all-cause mortality (secondary outcome) within 180 days of first prescription of zopiclone or trazodone with cause-specific hazard models and inverse probability of treatment weights to control for confounding; primary analysis was intention-totreat and secondary analysis was per-protocol (i.e., residents censored if dispensed the other exposure drug). Results Our cohort included 1,403 residents newly dispensed trazodone and 1,599 residents newly dispensed zopiclone. At cohort entry, the mean resident age was 85.7 (standard deviation [SD] 7.4), 61.6% were female, and 81.2% had dementia. New zopiclone use was associated with similar rates of injurious falls and major osteoporotic fractures (intention-to-treat-weighted hazard ratio 1.15, 95% confidence interval [CI] 0.90-1.48; perprotocol-weighted hazard ratio 0.85, 95% CI 0.60-1.21) and all-cause mortality (intention-to-treat-weighted hazard ratio 0.96, 95% CI 0.79-1.16; per-protocol-weighted hazard ratio 0.90, 95% CI 0.66-1.23) compared to trazodone. Conclusions Zopiclone was associated with a similar rate of injurious falls, major osteoporotic fractures, and all-cause mortality compared to trazodone--suggesting one medication should not be used in lieu of the other. Appropriate prescribing initiatives should also target zopiclone and trazodone.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N